AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 77 filers reported holding AEVI GENOMIC MEDICINE INC in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $19,000 | +11.8% | 15,143 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $17,000 | -43.3% | 15,143 | 0.0% | 0.00% | -33.3% |
| Q1 2018 | $30,000 | +66.7% | 15,143 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $18,000 | -5.3% | 15,143 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $19,000 | -5.0% | 15,143 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $20,000 | -28.6% | 15,143 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $28,000 | -64.1% | 15,143 | 0.0% | 0.00% | -63.6% |
| Q4 2016 | $78,000 | – | 15,143 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 128,000 | $257,000 | 0.17% |
| Baker Brothers Advisors | 4,055,142 | $8,151,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,500,000 | $11,055,000 | 0.03% |
| Verity Asset Management, Inc. | 10,000 | $20,000 | 0.02% |
| OneDigital Investment Advisors LLC | 10,850 | $22,000 | 0.01% |
| Legacy Advisors, LLC | 2,450 | $4,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 87,382 | $176,000 | 0.00% |
| HYMAN CHARLES D | 15,143 | $30,000 | 0.00% |
| Wealthcare Advisory Partners LLC | 5,000 | $10,000 | 0.00% |
| Kavar Capital Partners, LLC | 1,500 | $3,000 | 0.00% |